Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement.
about
H5N1 vaccines in humansEnhanced immunogenicity, mortality protection, and reduced viral brain invasion by alum adjuvant with an H5N1 split-virion vaccine in the ferretCross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primatesImmunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primatesThe avian influenza vaccine Emerflu. Why did it fail?Animal models in influenza vaccine testing.Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model.The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.Induction of long-term protective immune responses by influenza H5N1 virus-like particles.Current status and progress of prepandemic and pandemic influenza vaccine development.Emulsion-based adjuvants for influenza vaccines.Improving seasonal and pandemic influenza vaccinesA cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models.Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.Animal models for the preclinical evaluation of candidate influenza vaccines.Immunogenic and protective properties of the first Kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in ferrets.H5N1 pathogenesis studies in mammalian models.Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.Comparative Safety and Efficacy Profile of a Novel Oil in Water Vaccine Adjuvant Comprising Vitamins A and E and a Catechin in Protective Anti-Influenza Immunity.Dogs are highly susceptible to H5N1 avian influenza virus.CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adultsProteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus.Animal models for the study of influenza pathogenesis and therapy.Animal models in virus research: their utility and limitations.
P2860
Q27000896-41F49EDB-C850-4A5E-AE6E-5501E9F8A062Q27336156-6D64FC91-6AD1-45D7-987F-EADEEB286974Q27348520-ED3D083C-A417-46C7-9DC1-F661015DA900Q28475369-13E2D7D0-3B41-4FC1-8CAF-A306BFA29682Q30203302-07E2E6DA-0102-4FB8-936C-4A5208B6B1A6Q30371058-3488BB2D-3FCE-494B-A508-DFDB789E7A56Q30372159-8BEA40B6-838F-4F4F-9F19-071F18BD048FQ30372479-986621A1-05D4-440A-9C99-05B87C90DEDEQ30375255-10CCE172-65D6-4310-BCBA-35D9FD9BB46AQ30375975-2D09396C-22EF-42CD-A093-F26F8C9F7C51Q30375985-6834BE90-86B6-4CB8-8819-5D32B3498381Q30377211-A7C440E8-16C1-4A28-9416-0B62D8B66901Q30377246-86E63AEE-C05D-4B64-A172-7434E11EDC0EQ30379493-57DF4D2A-2C1A-40FE-A721-4E6737F31FB6Q30382567-BCB30321-EA2F-4DB8-AD95-0C6E9D2ABBEFQ30383623-7B5276D5-CE78-43C2-BDED-9390932B0779Q30424002-29434963-B52C-4ECA-84AF-E161FADABDF2Q30427806-0880EAD5-417F-4B5B-BF42-AEFD159A27DDQ33396140-D0684A8F-C49F-43F7-98A9-48F4176AE6B2Q33749602-B51EA7BE-26FD-4EF7-94D4-A277A55F7360Q34037274-3BCC14BD-6D9F-402C-91C6-2F9CE12ADCD4Q34104346-C37A886A-891B-4D7E-A2D6-4B3943C1BECDQ35151690-A2B2C8A6-E6FB-4024-A3A1-0F00CA9B6019Q37157152-5952CF7B-470D-4F87-AB1E-76096DCB955DQ37379466-8811ECC7-9996-4F4D-BB09-EFCD88A7310BQ38043556-37543CC6-8AAF-47DA-8016-964D5C61B2A2
P2860
Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Vaccination of macaques with a ...... e without disease enhancement.
@ast
Vaccination of macaques with a ...... e without disease enhancement.
@en
type
label
Vaccination of macaques with a ...... e without disease enhancement.
@ast
Vaccination of macaques with a ...... e without disease enhancement.
@en
prefLabel
Vaccination of macaques with a ...... e without disease enhancement.
@ast
Vaccination of macaques with a ...... e without disease enhancement.
@en
P2093
P2860
P356
P1433
P1476
Vaccination of macaques with a ...... e without disease enhancement.
@en
P2093
Alexandre Bidaut
Caroline Ruat
Catherine Caillet
James Simon
P2860
P304
P356
10.1128/JVI.01928-07
P407
P50
P577
2007-12-19T00:00:00Z